Purple Biotech Ltd. American Depositary Shares (PPBT)
Company News
Purple Biotech received a Nasdaq letter indicating non-compliance with minimum bid price requirements, with 180 days to regain compliance by raising its stock price above $1.00 per share.
Purple Biotech Ltd. Sponsored ADR (PPBT) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Shares of Green Giant Inc. (NASDAQ: GGE) fell sharply in pre-market trading after announcing a proposed public offering. Green Giant shares dipped 37.1% to $0.1599 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers NextPlay Technologies, Inc. (NASDAQ: NXTP) shares rose 62.8% to $0.6841 in pre-market trading...